Atherosclerosis CME Research 
Cardiometabolic Health Congress
OCTOBER 25, 2024
The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis.
Cardiometabolic Health Congress
AUGUST 14, 2024
CME-Supported Satellites and Sessions: Primetime CME Symposium Integrated Approach to Cardiorenal Management: Maximizing SGLT2 Inhibitor Benefits and Early Detection of HF and CKD Supported by an educational grant from BI-Lilly. Chair: Erin D. Michos, MD Presenters: Chiadi Ndumele, MD; Pam R. Co-Presenters: Diana Barb, MD; Mitchell L.
Cardiometabolic Health Congress
AUGUST 23, 2024
Updated with the latest research since the 2020 edition, this comprehensive report underscores the potential to prevent or significantly delay dementia by targeting modifiable risk factors. Key Takeaways: Up to 50% of all dementia cases could potentially be prevented or substantially delayed.
Cardiometabolic Health Congress
DECEMBER 5, 2024
AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Bridging Research and Clinical Practice The PHARM-HF trial evaluated strategies to optimize HF medication management in primary care, showing the effectiveness of audit and feedback. Earn 14 CME credits anytime on any device.
Cardiometabolic Health Congress
NOVEMBER 14, 2024
cardiometabolic health CME/CE conference: the 19th Annual CMHC. 3 SGLT2i as Foundational Therapy for Cardio-Kidney Protection PME CME Session: “SGLT2i as Foundational Therapy for Cardio-Kidney Protection” Presenter: Erin D. Here are the five most-cited takeaways from this year’s attendees.
Expert insights. Personalized for you.
64 
Let's personalize your content